Funder: Crohn's and Colitis Foundation
Due Dates: June 30, 2026 (Pre-application) | October 1, 2026 (Full proposal)
Funding Amounts: Up to $900,000 total over 3 years ($300,000/year, contingent on milestones; indirect costs capped at 10%).
Summary: Funds preclinical, translational research on immunology-based strategies to prevent postoperative recurrence of IBD, emphasizing immune training over broad immunosuppression.
Key Information: Both a senior PI and a junior Co-PI are required; international applicants are eligible.